Autor: |
van der Westhuizen HM; Global Health Security Consortium, United Kingdom.; Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom., Soundararajan S; Global Health Security Consortium, United Kingdom.; Tony Blair Institute for Global Change, United Kingdom., Berry T; Global Health Security Consortium, United Kingdom.; Ellison Institute of Technology, United Kingdom.; Population Health Partners, United Kingdom., Agus D; Global Health Security Consortium, United Kingdom.; Ellison Institute of Technology, United States of America., Carmona S; FIND, Switzerland., Ma P; Prognomiq, United States of America., Davis J; Northeastern University, United States of America., Walker S; Nuffield Department of Medicine, University of Oxford, United Kingdom., Mokaya J; Wellcome Sanger Institute, United Kingdom., Bentley SD; Wellcome Sanger Institute, United Kingdom., Thomson NR; Wellcome Sanger Institute, United Kingdom., Silitoe J; Wellcome Sanger Institute, United Kingdom., Singer A; UK Centre for Ecology and Hydrology, United Kingdom., Hassan I; Global Health Security Consortium, United Kingdom.; Tony Blair Institute for Global Change, United Kingdom., Mariano R; Global Health Security Consortium, United Kingdom.; Tony Blair Institute for Global Change, United Kingdom., Akodu M; Global Health Security Consortium, United Kingdom.; Ellison Institute of Technology, United Kingdom., Seidman G; Global Health Security Consortium, United Kingdom.; Ellison Institute of Technology, United States of America., Sachedina N; Oxford Nanopore Technologies, United Kingdom., Edgeworth J; Oxford Nanopore Technologies, United Kingdom.; Guy's & St Thomas' NHS Foundation Trust, United Kingdom., Naidoo R; Nuffield Department of Medicine, University of Oxford, United Kingdom.; Ernst & Young, United Kingdom., Makadzange T; Charles River Medical Group, Zimbabwe., Choi V; Tony Blair Institute for Global Change, United Kingdom., Gadde R; Global Diagnostics, Clinton Health Access Initiative, United States of America., Scarpino SV; Northeastern University, United States of America.; Santa Fe Institute, United States of America., Bull C; Ellison Institute of Technology, United Kingdom., Govender K; Ellison Institute of Technology, United Kingdom.; Nuffield Department of Medicine, University of Oxford, United Kingdom., Ngongo B; Illumina Inc., United Kingdom., Ruton H; Africa Quantitative Sciences, Rwanda., Pronyk P; Duke-NUS Centre for Outbreak Preparedness, Singapore, Singapore.; SingHealth Duke-NUS Global Health Institute, Singapore, Singapore., Smolina K; British Columbia Centre for Disease Control; and University of British Columbia Canada., Li H; Global Health Security Consortium, United Kingdom.; Tony Blair Institute for Global Change, United Kingdom., Barry D; The Global Commission for Post-Pandemic Policy, United Kingdom., Schaffer S; Illumina Inc., Munich, Germany., Moeder V; Independent Global Health Consultant, United States of America., Gao G; D. H. Chen School of Universal Health, Zhejiang University; Hangzhou, Zhejiang Province, China., Crook D; Nuffield Department of Medicine, University of Oxford, United Kingdom., Bell J; Global Health Security Consortium, United Kingdom.; Ellison Institute of Technology, United Kingdom.; Nuffield Department of Medicine, University of Oxford, United Kingdom. |
Abstrakt: |
Competing Interests: TB, JB, DC are current board members of the Global Pathogen Analysis Service Limited. DA and TM are previous board members of the Global Pathogen Analysis Service Limited. NS and JE are employed by Oxford Nanopore Technologies, where they also receive stock options. S Scarpino has options in Iliad biotechnologies. CB and KG were previously employed by the Global Pathogen Analysis Service Limited. BN is employed by Illumina Inc. where she also receives stock options. VM holds Illumina Inc stocks as a former employee. S Schaffer holds stock and stock options in Ilumina Inc and stock options in Hologic Inc. This does not alter our adherence to PLOS Global Public Health policies on sharing data and materials. HvdW, S Soundararajan, SC, PM, JD, DB, SW, JM, SB, NRT, JS, AS, IH, RM, MA, GS, RN, VC, RG, HR, PP, KS, HL and GG have no competing interests to declare. There are no patents products in development or marketed products associated with this research to declare. |